Rolvedon Injection, Solution
Product Images NDC 76961-101

The text is a table showing the percentage of patients in Study 1 and Study 2 who had severe neutropenia and the duration of this condition during Cycle 1. The table also displays the percentage of patients who did not have severe neutropenia, as well as the number of days it persisted. The treatment options used in the studies were DPegfigrastim and a resolved option.*

This appears to be a label of a medicine product named "Efalpegastim-xnst Injection" manufactured by Spectrum Pharmaceuticals, Inc. The specific dose of the medication seems to be 13.2mg/0.6mL. The identification number or code of the medication might be (01) 003 76961-101-01 9. The remaining text does not appear to be readable.*

This is a description of ROLVEDON, a sterile solution in a single-dose pre-filled syringe, which contains eflapegrastim-xnst (13.2 mg/0.6mL) and is intended for subcutaneous injection by a healthcare provider only. The solution consists of citric acid monohydrate, mannitol, polysorbate 80, and sodium chloride in water for injection. It does not contain any preservatives. The pH may be adjusted during manufacturing. The dosage should be followed as per the prescription. The product is stored in a refrigerator at a temperature between 2°C to 8°C, and should not be frozen or shaken. This product is manufactured by Spectrum Pharmaceuticals, Inc., USA, and is a product of the Republic of Korea.*